EXUVIANCE DAILY ACNE PEEL- salicylic acid liquid 
NeoStrata Company Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Exuviance® Daily Acne Peel

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

Do not use during pregnancy/lactation

keep out of eyes

Rinse with water to remove

When using this product

  • Using other topical acne medications at the same time or right after use of this product may increase dryness or irritation of the skin. Only one medication should be used unless directed by a doctor

Stop use and ask a doctor if

  • Too much skin irritation or sensitivity develops or increases

Keep out of reach of children.

If swallowed, get medical help or contact a poison control center right away

Flammable- keep away from fire or flame

Directions

Other information

Inactive ingredients

Alcohol Denat., Diisopropyl Adipate, Cyclopentasiloxane, Propylene Glycol, Triethyl Citrate, Cyclohexasiloxane, Citric Acid, Tartaric Acid, BHT.

Questions or comments?

Call toll free 1-800-225-9411 (9am – 5pm ET)

PRINCIPAL DISPLAY PANEL - 100 mL Bottle Carton

exuviance ®

FOCUS

oily
acne prone
DAILY ACNE
PEEL
Clear blemishes,
black/white-heads
Formulated to
smooth texture,
reduce oiliness

2% Salicylic Acid
acne solution
Citric Acid and
Tartaric Acid
CitraFill

100 mL/3.4 fl oz

PRINCIPAL DISPLAY PANEL - 100 mL Bottle Carton
EXUVIANCE DAILY ACNE PEEL 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58414-0017
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
DIISOPROPYL ADIPATE (UNII: P7E6YFV72X)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
TARTARIC ACID (UNII: W4888I119H)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58414-0017-11 in 1 CARTON06/15/201809/30/2021
150 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
2NDC:58414-0017-21 in 1 CARTON12/01/2019
2100 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333D06/15/2018
Labeler - NeoStrata Company Inc. (605754829)

Revised: 8/2023
Document Id: 54b2fd4f-faf2-4ff1-adde-effab0a5ea1e
Set id: e9f7da8a-c595-4500-89f1-ec8a2a72ef59
Version: 5
Effective Time: 20230830
 
NeoStrata Company Inc.